A group of scientists, including individuals from the College of Connecticut, has fostered a nanoparticle-based therapy that targets various offenders in glioblastoma, an especially forceful and lethal type of brain disease. The outcomes of a cooperation among UConn and Yale College were distributed today in Science Advances. The new treatment utilizes bioadhesive nanoparticles that stick to the site of the growth and, afterward, leisurely deliver the blended peptide nucleic acids that they're conveying. These peptide nucleic acids focus on specific microRNAs, that is, short strands of RNA that play a part in quality articulation. They are specifically targeting a type















